enow.com Web Search

Search results

  1. Results from the WOW.Com Content Network
  2. Amgen (AMGN) to Report Q3 Earnings: What's in the Cards? - AOL

    www.aol.com/news/amgen-amgn-report-q3-earnings...

    Volume growth of Amgen's (AMGN) key drugs like Prolia, Kyprolis, Repatha and others and biosimilars portfolio is expected to have been partially offset by biosimilar/generic competition for mature ...

  3. Amgen (AMGN) Q4 2024 Earnings Call Transcript - AOL

    www.aol.com/finance/amgen-amgn-q4-2024-earnings...

    Image source: The Motley Fool. Amgen (NASDAQ: AMGN) Q4 2024 Earnings Call Feb 04, 2025, 4:30 p.m. ET. Contents: Prepared Remarks. Questions and Answers. Call ...

  4. Amgen (AMGN) to Report Q3 Earnings: What's in the Cards? - AOL

    www.aol.com/news/amgen-amgn-report-q3-earnings...

    Volume growth from Amgen's (AMGN) key drugs like Prolia, Xgeva, Repatha and others is expected to have been partially offset by biosimilar/generic competition for mature drugs.

  5. Amgen's peek at its GLP-1 drug trial results heightens ... - AOL

    www.aol.com/finance/amgens-peek-glp-1-drug...

    Amgen's positive trial results update on its GLP-1 injectable for obesity, MariTide, sent its stock up more than 13% in trading Friday.CEO Bob Bradway shared a peek at phase II results of the ...

  6. List of largest pharmaceutical mergers and acquisitions

    en.wikipedia.org/wiki/List_of_largest...

    Rank Year Purchaser Target Value (in billions USD) Value (adjusted for inflation) 1 2015 Pfizer: Allergan, plc: 160 206 In November 2015 Pfizer announced it would acquire Allergan, plc for $160 billion ($206 billion, adjusted for inflation).

  7. Amgen (AMGN) Down 2.2% Since Last Earnings Report: Can It ...

    www.aol.com/news/amgen-amgn-down-2-2-153103577.html

    For premium support please call: 800-290-4726 more ways to reach us

  8. Analysis-Wall Street awaits Amgen weight-loss drug data ... - AOL

    www.aol.com/analysis-wall-street-awaits-amgen...

    Upcoming data from a mid-stage study of Amgen's experimental weight-loss drug MariTide will shed light on how well it might measure up against the popular GLP-1 drugs sold by Eli Lilly and Novo ...

  9. Why Is Amgen (AMGN) Up 0.5% Since Last Earnings Report? - AOL

    www.aol.com/news/why-amgen-amgn-0-5-153103499.html

    For premium support please call: 800-290-4726 more ways to reach us